Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder.
Otka
J E
JE
Mercadante
M T
MT
Scahill
L
L
Leckman
J F
JF
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D000077593:Reboxetine
D018759:Adrenergic Uptake Inhibitors; D009025:Morpholines; D000077593:Reboxetine